VC
Vivo Capital Portfolio holdings
AUM
$977M
1-Year Return
209.68%
This Quarter Return
-5.46%
1 Year Return
+209.68%
3 Year Return
+1,480.07%
5 Year Return
+2,591.98%
10 Year Return
–
AUM
$1.1B
AUM Growth
-$269M
(-20%)
Cap. Flow
-$269M
Cap. Flow
% of AUM
-24.35%
Top 10 Holdings %
Top 10 Hldgs %
61.03%
Holding
57
New
53
Increased
–
Reduced
–
Closed
4
Top Buys
| 1 |
Ascendis Pharma
ASND
|
+$226M |
| 2 |
NFH
New Frontier Health Corporation Ordinary Shares
NFH
|
+$118M |
| 3 |
KDMN
Kadmon Holdings, Inc.
KDMN
|
+$52.5M |
| 4 |
Arcutis Biotherapeutics
ARQT
|
+$50.3M |
| 5 |
Crinetics Pharmaceuticals
CRNX
|
+$48.8M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 87.06% |
| 2 | Financials | 10.69% |
| 3 | Materials | 1.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
DBVT
51
DBV Technologies
DBVT
$270M
| $1.06M | 0.1% |
+27,000
| New | +$1.06M |
|
|
NBRV
52
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
| $980K | 0.09% |
+6,817
| New | +$980K |
|
53
Precision BioSciences
DTIL
$54.3M
| $846K | 0.08% |
+4,675
| New | +$846K |
|